Torthaí cuardaigh - Navdeep Pal

  • 1 - 8 toradh as 8 á dtaispeáint
Beachtaigh na torthaí
  1. 1
    Overall survival in patients with advanced non-small cell lung cancer with KRAS G12C mutation with or without STK11 and/or KEAP1 mutations in a real-world setting

    Overall survival in patients with advanced non-small cell lung cancer with KRAS G12C mutation with or without STK11 and/or KEAP1 mutations in a real-world setting de réir Cristina Julián, Navdeep Pal, Anda Gershon, Marie Evangelista, Hans E. Purkey, Peter Lambert, Zhen Shi, Qing Zhang

    Foilsithe / Cruthaithe 2023
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    Overall survival after pelvic exenteration for gynecologic malignancy

    Overall survival after pelvic exenteration for gynecologic malignancy de réir Shannon N. Westin, Vijayashri Rallapalli, Bryan Fellman, Diana L. Urbauer, Navdeep Pal, Michael Frumovitz, Lois M. Ramondetta, Diane C. Bodurka, Pedro T. Ramírez, Pamela T. Soliman

    Foilsithe / Cruthaithe 2014
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    Evaluating eligibility criteria of oncology trials using real-world data and AI

    Evaluating eligibility criteria of oncology trials using real-world data and AI de réir Ruishan Liu, Shemra Rizzo, Samuel Whipple, Navdeep Pal, Arturo López Pineda, Michael W. Lu, Brandon Arnieri, Ying Lü, William B. Capra, Ryan Copping, James Zou

    Foilsithe / Cruthaithe 2021
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 4
    Effectiveness of PD-(L)1 inhibitors alone or in combination with platinum-doublet chemotherapy in first-line (1L) non-squamous non-small-cell lung cancer (Nsq-NSCLC) with PD-L1-high expression using real-world data

    Effectiveness of PD-(L)1 inhibitors alone or in combination with platinum-doublet chemotherapy in first-line (1L) non-squamous non-small-cell lung cancer (Nsq-NSCLC) with PD-L1-hig... de réir M. Pérol, Enriqueta Felip, Urania Dafni, Letizia Polito, Navdeep Pal, Zoi Tsourti, Thanh G.N. Ton, David M. Merritt, S. Morris, Rolf A. Stahel, Solange Peters

    Foilsithe / Cruthaithe 2022
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  5. 5
    Systematic analysis of off-label and off-guideline cancer therapy usage in a real-world cohort of 165,912 US patients

    Systematic analysis of off-label and off-guideline cancer therapy usage in a real-world cohort of 165,912 US patients de réir Ruishan Liu, Lisa Wang, Shemra Rizzo, Marius Garmhausen, Navdeep Pal, Sarah Waliany, Sarah F. McGough, Yvonne G. Lin, Zhi Huang, Joel W. Neal, Ryan Copping, James Zou

    Foilsithe / Cruthaithe 2024
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  6. 6
    Treatment of Low-Risk Endometrial Cancer and Complex Atypical Hyperplasia With the Levonorgestrel-Releasing Intrauterine Device

    Treatment of Low-Risk Endometrial Cancer and Complex Atypical Hyperplasia With the Levonorgestrel-Releasing Intrauterine Device de réir Navdeep Pal, Russell R. Broaddus, Diana L. Urbauer, Nyla Balakrishnan, Andrea Milbourne, Kathleen M. Schmeler, Larissa A. Meyer, Pamela T. Soliman, Karen H. Lu, Pedro T. Ramírez, Lois M. Ramondetta, Diane C. Bodurka, Shannon N. Westin

    Foilsithe / Cruthaithe 2017
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  7. 7
    PTEN loss is a context-dependent outcome determinant in obese and non-obese endometrioid endometrial cancer patients

    PTEN loss is a context-dependent outcome determinant in obese and non-obese endometrioid endometrial cancer patients de réir Shannon N. Westin, Zhenlin Ju, Russell R. Broaddus, Camilla Krakstad, Jane Li, Navdeep Pal, Karen H. Lu, Robert L. Coleman, Bryan T. Hennessy, Samuel J. Klempner, Henrica M.J. Werner, Helga B. Salvesen, Lewis C. Cantley, Gordon B. Mills, Andrea P. Myers

    Foilsithe / Cruthaithe 2015
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  8. 8
    Prospective phase II trial of levonorgestrel intrauterine device: nonsurgical approach for complex atypical hyperplasia and early-stage endometrial cancer

    Prospective phase II trial of levonorgestrel intrauterine device: nonsurgical approach for complex atypical hyperplasia and early-stage endometrial cancer de réir Shannon N. Westin, Bryan Fellman, Charlotte C. Sun, Russell R. Broaddus, Misty Woodall, Navdeep Pal, Diana L. Urbauer, Lois M. Ramondetta, Kathleen M. Schmeler, Pamela T. Soliman, Nicole D. Fleming, Jennifer K. Burzawa, Alpa M. Nick, Andrea Milbourne, Ying Yuan, Karen H. Lu, Diane C. Bodurka, Robert L. Coleman, Melinda S. Yates

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: